TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
194
Frequently Asked Questions
What is Market Cap of Tscan Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tscan Therapeutics Inc market cap is $107.25M.
What is the 52-week high for Tscan Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tscan Therapeutics Inc 52 week high is $6.23 as of September 06, 2025.
What is the 52-week low for Tscan Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tscan Therapeutics Inc 52 week low is $1.02 as of September 06, 2025.
What is Tscan Therapeutics Inc stock price today?
Tscan Therapeutics Inc stock price today is $1.91.
What was Tscan Therapeutics Inc stock price yesterday?
Tscan Therapeutics Inc stock price yesterday was $1.89.
What is the PE ratio of Tscan Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tscan Therapeutics Inc’s P/E ratio is -1.72.
What is the Price-to-Book ratio of Tscan Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tscan Therapeutics Inc P/B ratio is 0.6069.
What is the 50-day moving average of Tscan Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tscan Therapeutics Inc 50-day moving average is $1.74.
How many employess does Tscan Therapeutics Inc has?